Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by IKTOS

Iktos appoints new Scientific Advisory Board with world-renowned AI and Drug Discovery experts to accelerate the development of novel therapies
From IKTOS
Via GlobeNewswire
Iktos acquires Synsight, a life sciences technology company specializing in protein-protein and RNA-protein interactions-targeted drug discovery
From IKTOS
Via GlobeNewswire
Italfarmaco partners with Iktos on artificial intelligence to speed drug discovery breakthroughs for patients
From IKTOS
Via GlobeNewswire
Iktos announces the appointment of Roman Fleck as Chairman of the Board
From IKTOS
Via GlobeNewswire
Iktos opens a subsidiary in Japan and entrusts its management to Hideyoshi Fuji
From IKTOS
Via GlobeNewswire
Iktos announces the appointment of Avirup Bose as Chief Business Officer
From IKTOS
Via GlobeNewswire
Iktos and Bayer Announce Collaboration to expand the use of Artificial Intelligence to Design New Sustainable Crop Protection Solutions
From IKTOS
Via GlobeNewswire
Correction: Kissei introduces Iktos AI Drug Discovery System
From IKTOS
Via GlobeNewswire
Kissei introduces Iktos AI Drug Discovery System
From IKTOS
Via GlobeNewswire
Iktos and Curreio Announce Collaboration Agreement in New Drug Discovery
From Iktos
Via Business Wire
Iktos Partners with Medicines for Malaria Venture in Anti-Malarial Drug Discovery
From Iktos
Via Business Wire
Iktos Announces Collaboration With Galapagos in AI For Drug Design
From Iktos
Via Business Wire
Iktos and Zealand Pharma to Develop Artificial Intelligence Technology for Peptide Drug Design
From Iktos
Via Business Wire
Sygnature Discovery to Deploy Iktos’s AI for Drug Design Software Makya™
From Iktos
Via Business Wire
Iktos and Teijin Pharma to Co-Develop New Technology for Small Molecule Drug Discovery
From Iktos
Via Business Wire
Iktos Announces a Collaboration With Ono in Artificial Intelligence for New Drug Design
From Iktos
Via Business Wire
Iktos and Astrogen Announce a Research Collaboration to Use Artificial Intelligence Platform for Drug Design against a Novel Parkinson’s Disease Target
From Iktos
Via Business Wire
Iktos and The University of Dundee, Drug Discovery Unit (DDU) Announce a Collaboration to Use AI for Drug Design and Retrosyntheis
From Iktos
Via Business Wire
Iktos Announces Deployment of Their AI for Drug Design Software Makya™ by Jiangsu Hengrui Pharmaceuticals Co., Ltd.
From Iktos
Via Business Wire
Iktos Announces Deployment of their AI for Drug Design Software Makya™ by Chiesi Group
From Iktos
Via Business Wire
Iktos Announce Collaboration with UCB in AI for Retrosynthesis
From Iktos
Via Business Wire
Iktos Announces Collaboration with Kadmon to Use AI for New Drug Design
From Iktos
Via Business Wire
Iktos and Facio Therapies Announce Collaboration to Use AI for FSHD Drug Design
From Iktos
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.